Refine
Has Fulltext
- yes (7)
Is part of the Bibliography
- yes (7)
Document Type
- Journal article (7)
Language
- English (7)
Keywords
- Malignant hyperthermia (2)
- Succinylcholine (2)
- malignant hyperthermia (2)
- skeletal muscle (2)
- Emery-Dreifuss muscular dystrophy (1)
- Halothane (1)
- In vitro contracture test (1)
- Medizin (1)
- New Zealand (1)
- North American (1)
- RyR1 mutations (1)
- Swine (1)
- Volatile anesthetics (1)
- caffeine (1)
- central core disease (1)
- halothane (1)
- in vitro contracture test (1)
- inhalation anesthetics (1)
- levosimendan (1)
- microdialysis (1)
- muscle (1)
- pigs (1)
- ryanodine receptor gene (1)
- sarcoplasmic reticulum (1)
- succinylcholine (1)
- susceptibility (1)
- suxamethonium (1)
- ultrasound strain elastography (1)
- vitro contracture test (1)
- volatile anesthetics (1)
Institute
Malignant hyperthermia is a rare but life-threatening complication of general anesthesia in predisposed patients usually triggered by potent inhalation anesthetics and/or the depolarizing muscle relaxant succinylcholine. The authors present a case of delayed sevoflurane-induced malignant hyperthermia in a 21-year-old male patient that was sufficiently treated by discontinuation of trigger agent application and dantrolene infusion. After surviving an MH episode diagnostic procedures are indicated to increase patient safety. In the presented case, the use of a novel minimal-invasive metabolic test with intramuscular injection of halothane and caffeine successfully confirmed MH susceptibility and hence might be an alternative for invasive in vitro contracture testing in selected cases.